CONMED reported third quarter 2026 net sales of $335.6 million, down 0.7% from a year earlier, and adjusted diluted EPS of $1.04, down 3.2%. GAAP diluted EPS was $0.66, up from $0.09, and the company updated its full year 2026 guidance to net sales of $1,360 million to $1,366 million and adjusted diluted EPS of $4.54 to $4.61. The picture is mixed for shareholders: the adjusted EPS range moved higher, while the top end of the sales range was lowered.
Third quarter net sales were $335.6 million, down 0.7%; excluding GI product offering exits, organic constant currency net sales grew 6.7%.
Domestic sales fell 11.0% as reported, while international sales rose 13.1% as reported.
Full year 2026 net sales guidance is $1,360 million to $1,366 million, versus prior guidance of $1,358 million to $1,373 million.
Full year 2026 adjusted diluted EPS guidance is $4.54 to $4.61, versus prior guidance of $4.48 to $4.60.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
From CONMED Corporation's 10-Q and 10-K filings (SEC XBRL). YoY compares each quarter with the same quarter a year earlier; it is blank when the year-ago figure is missing or negative.
Annual results
Fiscal year
Revenue
Growth
EPS (diluted)
Growth
Net margin
FY2025
$1.37B
+5.2%
$1.51
-64.5%
3.4%
FY2024
$1.31B
+5.0%
$4.25
+108.3%
10.1%
FY2023
$1.24B
+19.1%
$2.04
—
5.2%
FY2022
$1.05B
+3.4%
$-2.68
-238.1%
-7.7%
FY2021
$1.01B
+17.2%
$1.94
+506.2%
6.2%
Frequently asked questions
When is CONMED's next earnings date?
CONMED has not announced a report date within the next three weeks. US companies usually report three to six weeks after each quarter ends; this page updates as soon as the date is on the calendar.
What did CONMED earn last quarter?
For the quarter ended Sep 2026, CONMED reported diluted EPS of $0.66 (+633.3% year over year) on revenue of $335.56M (-0.7%).
Where do these numbers come from?
Reported revenue, net income and EPS come from the company's own 10-Q and 10-K filings with the SEC (XBRL data). The report date and consensus estimate come from the Nasdaq earnings calendar.
Not investment advice. Figures can be restated by the company in later filings.